Many promising peptides fail because they degrade too easily. This limits their usefulness in drug design and creates ...

A new comprehensive report by Ameco Research projects that the Peptide Synthesis Market is on track for substantial growth ...

The U.S. Peptide Therapeutics Retail Market offers growth opportunities driven by increased healthcare spending and demand ...

Officials at India-based Syngene International, a CRDMO, report that the company executed site upgrades to accelerate drug discovery and development. The investments included a dedicated peptide ...

As of Monday, November 10, Mesa Laboratories, Inc.’s MLAB share price has surged by 5.38%, which has investors questioning if ...

"The investment in our California facility represents a key milestone in our strategic growth and demonstrates an unwavering dedication to the domestic biopharma sector,” said Joerg Ahlgrimm, CEO of ...

ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE(R) SL Self-Loading MHC Class I Monomers. The novel reagents for antigen-specific CD8+ ...

ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE® SL Self-Loading MHC Class I Monomers.

Imagine a country facing rising tensions with its neighbors. In a small research lab that looks no different from hundreds of ...

Susan Lois Hamilton, chair of the Department of Integrated Physiology, received her Ph.D. in biophysics from the University ...